Industry / Biological Product (except Diagnostic) Manufacturing
Trending Companies
Latest filings
144
FUSN
Fusion Pharmaceuticals
8 Dec 23
Notice of proposed sale of securities
5:36pm
PRE 14A
SABS
SAB Biotherapeutics
8 Dec 23
Preliminary proxy
5:26pm
SC 13E3
FRLN
Freeline Therapeutics
8 Dec 23
Going private transaction
5:21pm
8-K
HLVX
HilleVax
8 Dec 23
Amendments to Articles of Incorporation or Bylaws
5:11pm
8-K
TCON
TRACON Pharmaceuticals
8 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
6-K
EVAX
Evaxion Biotech A/S
8 Dec 23
Current report (foreign)
4:45pm
144/A
VCEL
Vericel
8 Dec 23
Notice of proposed sale of securities (amended)
4:39pm
144/A
VCEL
Vericel
8 Dec 23
Notice of proposed sale of securities (amended)
4:21pm
8-K
AGEN
Agenus
8 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
ADVM
Adverum Biotechnologies
8 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:11pm
Upcoming Earnings Releases
CSBR
Champions Oncology
$67.7 mm
13 Dec 23
PMCB
PharmaCyte Biotech
$19.8 mm
14 Dec 23
CVM
Cel-Sci
$132.9 mm
27 Dec 23
OTLK
Outlook Therapeutics
$110.4 mm
28 Dec 23
AMGN
AMGEN
$144,000.4 mm
30 Jan 24
GILD
Gilead Sciences
$98,412.4 mm
1 Feb 24
TECH
Bio-Techne
$10,801.7 mm
1 Feb 24
IMVT
Immunovant
$5,670.7 mm
2 Feb 24
QGEN
Qiagen
$9,523.6 mm
6 Feb 24
NBIX
Neurocrine Biosciences
$11,520.0 mm
6 Feb 24
Latest IPO Filings (S1/F1/S11)
S-1
WINT
Windtree Therapeutics
14 Feb 23
S-1
ZIVO
Zivo Bioscience
22 Mar 23
S-1
PALI
Palisade Bio
21 Apr 23
S-1
TCON
TRACON Pharmaceuticals
19 May 23
S-1
APTO
Aptose Biosciences
16 Jun 23
S-1
TTNP
Titan Pharmaceuticals, Inc.
23 Jun 23
S-1
MBOT
Microbot Medical
11 Jul 23
S-1
ZIVO
Zivo Bioscience
4 Oct 23
F-1
SCNI
Scinai Immunotherapeutics
30 Oct 23
S-1
APTO
Aptose Biosciences
1 Dec 23
Stock splits Upcoming and recent stock splits
News
Aptose Tuspetinib Clinical Data Featured In Oral Presentation Saturday At 2023 ASH Meeting; Said TUS/VEN Combination Active Across Broad Populations Of AML And Demonstrates 25% Complete Response Rate Among All-comers, Including 20% CRc In Wildtype AML
APTO
10 Dec 23
Autolus Therapeutics Presented Clinical Data Updates Saturday At 2023 ASH Meeting
AUTL
10 Dec 23
Harpoon Therapeutics, Inc. Files Prospectus For The Offering and Resale Of 25,751,025 Shares Of Common Stock By Selling Stockholders
HARP
8 Dec 23
FDA Approves First Gene-Editing Cell Therapy For Sickle Cell Disease, An Inherited Blood Disorder
BLUE
CRSP
VRTX
8 Dec 23
Moderna's Options Frenzy: What You Need to Know
MRNA
8 Dec 23
Bluebird Bio Details Plans For The Commercial Launch Of LYFGENIA Gene Therapy For Patients Ages 12 And Older With Sickle Cell Disease And A History Of Vaso-Occlusive Events; Bluebird Has Set Wholesale Acquisition Cost Of LYFGENIA In U.S. At $3.1M
BLUE
8 Dec 23
Why Comtech Telecommunications Shares Are Trading Lower By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
AAGR
AGRO
ALXO
8 Dec 23
Truist Securities Reiterates Buy on CRISPR Therapeutics, Maintains $220 Price Target
CRSP
8 Dec 23
Vertex And CRISPR Therapeutics Announce U.S. FDA Approval Of CASGEVY For The Treatment Of Sickle Cell Disease
CRSP
VRTX
8 Dec 23
Mizuho Reiterates Buy on CRISPR Therapeutics, Maintains $82 Price Target
CRSP
8 Dec 23
Press releases
Long-Term Data Presented at ASH Support beti-cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb Levels
BLUE
10 Dec 23
Poseida Therapeutics Presents Positive Early Results from its Phase 1 Trial of Allogeneic CAR-T P-BCMA-ALLO1 in Relapsed-Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting
PSTX
10 Dec 23
Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant in Oral Presentation at ASH 2023
JSPR
10 Dec 23
BRAINSTORM DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Brainstorm To Contact Him Directly To Discuss Their Options
BCLI
10 Dec 23
OUTLOOK ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Outlook To Contact Him Directly To Discuss Their Options
OTLK
10 Dec 23
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Brainstorm Cell Therapeutics Inc. - BCLI
BCLI
10 Dec 23
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Outlook Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - OTLK
OTLK
10 Dec 23
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023
AUTL
9 Dec 23
Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting
APTO
9 Dec 23
X4 Pharmaceuticals Announces Presentation of Additional Data from Mavorixafor Phase 2 Trial in Chronic Neutropenia at ASH 2023
XFOR
9 Dec 23
Community annotations
Transcripts
AIM
Earnings call transcript
2023 Q3
15 Nov 23
IKT
Earnings call transcript
2023 Q3
15 Nov 23
TSHA
Earnings call transcript
2023 Q3
14 Nov 23
GMDA
Earnings call transcript
2023 Q3
14 Nov 23
BCLI
Earnings call transcript
2023 Q3
14 Nov 23
DMAC
Earnings call transcript
2023 Q3
14 Nov 23
ACOR
Earnings call transcript
2023 Q3
13 Nov 23
ABOS
Earnings call transcript
2023 Q3
13 Nov 23
APTO
Earnings call transcript
2023 Q3
9 Nov 23
HUMA
Earnings call transcript
2023 Q3
9 Nov 23
Patents
Utility
Pyrrole Compounds
7 Dec 23
Utility
Sustained Release Aminopyridine Composition
ACOR
7 Dec 23
Utility
Treatment of HER2 Positive Cancers
SGEN
7 Dec 23
Utility
Method of Treatment of Cancer or Tumour
ADAP
7 Dec 23
Utility
Engineered Ipsc and Persistent Immune Effector Cells
FATE
7 Dec 23
Utility
Fusobacterium Bacteriophage and Uses Thereof
PHGE
7 Dec 23
Utility
Multiplex Gene Edited Cells for CD70-DIRECTED Cancer Immunotherapy
CRSP
7 Dec 23
Utility
Vectorized Factor XII Antibodies and Administration Thereof
RGNX
7 Dec 23
Utility
Dihydroquinazolinones and Related Analogs for Inhibiting Yap/taz-tead
SWTX
7 Dec 23
Utility
GLP-1R Modulating Compounds
GILD
7 Dec 23
Reddit threads
Daily Discussion Thread - December 8th, 2023
CENN
SNCE
JOUT
8 Dec 23
Daily Plays December 07, 2023
MLGO
AVTX
RS
7 Dec 23
They printed $10 Trillion dollars, gave you a $1,400 stimulus check, gave the wealthy PPP loans that were forgiven, then left you with the inflation, higher costs of living and an 8% mortgage rate. Brilliant for a the rich, painful for you?
CARE
K
ERC
6 Dec 23
About a month ago I started investing, and a week ago I thought I’d try my hand at penny stocks. Goin pretty well so far!
ATRA
6 Dec 23
List of December's FDA/PDUFA catalyst and their Options sentiments
GTHX
ADC
JAZZ
5 Dec 23
Daily Discussion Thread - December 5th, 2023
ZVSA
AIH
ARVL
5 Dec 23
Daily Discussion Thread - December 4th, 2023
BNRG
GENE
HUT
4 Dec 23
$CBIA Canopus Biopharma, Inc. DD Overview
CBIA
BLUE
BHC
2 Dec 23
Is anything really a "forever stock?"
IBM
CRSP
AAPL
2 Dec 23
Daily Plays December 02, 2023
AIRE
CAUD
PTN
2 Dec 23